解析男性生殖系基因组以揭示其生殖潜能
该回顾性研究纳入31对不明原因不孕且精液参数正常的夫妇,按ICSI结局分为生育组与不育组,比较精子非整倍体及全外显子组测序的基因突变谱,发现不育亚组存在与卵子激活、胚胎发育、着床及流产相关的特定基因突变,并据此采用辅助配子处理或微流控精子处理获得成功妊娠。
要点
- 生育组精子非整倍体率4.0%,不育组8.4%。
- 受精失败亚组(n=4)PLCζ存在可忽略(10%±9%)并携带PLCZ1、PIWIL1、ADAM15突变,后续辅助配子处理成功。
- 早期胚胎发育不良亚组(n=5)异常中心体45.9%±5%,微流控精子处理后获足月妊娠。
核心结论
- 通过评估精子基因组,识别出与多种生殖过程相关的特定生殖系突变,可能阐明生殖能力的隐匿因素并改善不明原因不孕夫妇的治疗。
研究设计与样本
- 回顾性研究,纳入31对不明原因不孕且精液参数正常的夫妇,按是否获得成功ICSI结局分为生育组与不育组。
- 对精液进行辅助精子功能检测,对精子DNA进行全外显子组测序,比较两组精子非整倍体及基因突变谱,并按生殖失败具体原因分层。
- 对携带受精或胚胎发育相关基因突变的夫妇,分别采用辅助配子处理或微流控处理。
主要发现
- 生育组精子非整倍体率4.0%,不育组8.4%。
- 两组精子均显示与精卵融合(ADAM3A)及顶体发育(SPACA1)相关的突变,与生殖结局无关。
- 受精失败亚组(n=4)精子PLCζ存在可忽略(10%±9%),携带PLCZ1、PIWIL1、ADAM15突变,提示精子相关卵子激活缺陷,后续周期经辅助配子处理成功。
- 早期胚胎发育不良亚组(n=5)异常中心体45.9%±5%,携带影响中心体完整性(HAUS1)及纺锤体/微管稳定(KIF4A、XRN1)的突变,微流控精子处理后获足月妊娠。
- 着床失败亚组(n=7)异常中心体53.1%±13%,携带影响胚胎着床(IL9R)及微管与中心体完整性(MAP1S、SUPT5H、PLK4)的突变;流产亚组(n=5)携带滋养层发育(NLRP7)、细胞周期调控(MARK4、TRIP13、DAB2IP、KIF1C)及复发性流产(TP53)相关基因突变。
临床怎么用
- 作者认为,通过评估精子基因组识别与生殖过程相关的特定生殖系突变,可能阐明生殖能力的隐匿因素并改善不明原因不孕夫妇的治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify specific germline mutations related to sperm reproductive competence, in couples with unexplained infertility. DESIGN: In this retrospective study, couples were divided according to whether they had successful intracytoplasmic sperm injection outcomes (fertile) or not (infertile). Ancillary sperm function tests were performed on ejaculates, and whole exome sequencing was performed on spermatozoal DNA. Sperm aneuploidy and gene mutation profiles were compared between the 2 cohorts as well as according to the specific reasons for reproductive failure. SETTING: Center for reproductive medicine at a major academic medical center. PATIENT(S): Thirty-one couples with negative infertility workups and normal semen parameters. INTERVENTION(S): Couples with mutations on fertilization- or embryo development-related genes were subsequently treated by assisted gamete treatment or microfluidics, respectively. MAIN OUTCOME MEASURE(S): Intracytoplasmic sperm injection cycle outcomes including fertilization, clinical pregnancy, and delivery rates. RESULT(S): Sperm aneuploidy was lower in the fertile group (4.0% vs. 8.4%). Spermatozoa from both cohorts displayed mutations associated with sperm-egg fusion (ADAM3A) and acrosomal development (SPACA1), regardless of reproductive outcome. The infertile cohort was then categorized according to the reasons for reproductive failure: absent fertilization, poor early embryo development, implantation failure, or pregnancy loss. Spermatozoa from the fertilization failure subgroup (n = 4) had negligible PLCζ presence (10% ± 9%) and gene mutations (PLCZ1, PIWIL1, ADAM15) indicating a sperm-related oocyte-activating deficiency. These couples were successfully treated by assisted gamete treatment in their subsequent cycles. Spermatozoa from the poor early embryo development subgroup (n = 5) had abnormal centrosomes (45.9% ± 5%), and displayed mutations impacting centrosome integrity (HAUS1) and spindle/microtubular stabilization (KIF4A, XRN1). Microfluidic sperm processing subsequently yielded a term pregnancy. Spermatozoa from the implantation failure subgroup (n = 7) also had abnormal centrosomes (53.1% ± 13%) and carried mutations affecting embryonic implantation (IL9R) and microtubule and centrosomal integrity (MAP1S, SUPT5H, PLK4), whereas those from the pregnancy loss subgroup (n = 5) displayed mutations on genes involved in trophoblast development (NLRP7), cell cycle regulation (MARK4, TRIP13, DAB2IP, KIF1C), and recurrent miscarriage (TP53). CONCLUSION(S): By assessing the sperm genome, we identified specific germline mutations related to various reproductive processes. This information may clarify elusive factors underlying reproductive competence and enhance treatment for couples with unexplained infertility.
引用
- Cheung S, Xie P, Rosenwaks Z, et al. Profiling the male germline genome to unravel its reproductive potential. Fertil Steril. 2022. PMID: 36379263. doi:10.1016/j.fertnstert.2022.11.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。